RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
RESMED INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026
$239.77+0.80 (+0.33%)
Close on Oct 19, 2026
- Market cap
- $34.79B
- P/E (TTM)
- 23.0
- Dividend yield
- 1.00%
Resmed statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Resmed | Industry median |
|---|---|---|
| Market Cap | $34.59B | $229.23M |
| Enterprise Value | $33.38B | $194.73M |
| PE Ratio | 22.99 | 33.41 |
| PS Ratio | 6.12 | 3.14 |
| PB Ratio | 5.25 | 3.19 |
| P/TBV Ratio | 10.73 | 4.69 |
| P/FCF Ratio | 20.97 | 27.25 |
| P/OCF Ratio | 19.15 | 22.23 |
Enterprise value
| Measure | Resmed | Industry median |
|---|---|---|
| EV / Sales | 5.90 | 2.93 |
| EV / EBITDA | 15.99 | 19.97 |
| EV / EBIT | 17.69 | 25.47 |
| EV / FCF | 20.23 | 27.85 |
Income (trailing twelve months)
| Measure | Resmed | Industry median |
|---|---|---|
| Revenue | $5.65B | $102.39M |
| Gross Profit | $3.45B | $60.36M |
| Operating Income | $1.89B | -$4.31M |
| Pretax Income | $1.92B | -$2.26M |
| Net Income | $1.52B | -$6.57M |
| EBITDA | $2.09B | -$1.98M |
| EPS (Diluted) | $10.43 | -$0.07 |
Margins
| Measure | Resmed | Industry median |
|---|---|---|
| Gross Margin | 61.1% | 55.1% |
| Operating Margin | 33.4% | -6.04% |
| Pretax Margin | 34.0% | -4.11% |
| Profit Margin | 26.9% | -10.5% |
| EBITDA Margin | 36.9% | -2.67% |
| FCF Margin | 29.2% | -0.30% |
Returns
| Measure | Resmed | Industry median |
|---|---|---|
| Return on Equity (ROE) | 24.3% | -19.2% |
| Return on Assets (ROA) | 17.8% | -13.3% |
| Return on Invested Capital (ROIC) | 29.5% | -4.11% |
| Return on Capital Employed (ROCE) | 24.9% | -9.07% |
Growth
| Measure | Resmed | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 9.85% | 8.85% |
| Net Income Growth (YoY) | 8.75% | 10.6% |
| EPS Growth (YoY) | 9.67% | 10.6% |
| FCF Growth (YoY) | -0.73% | 10.6% |
| Revenue Growth (3Y CAGR) | 10.2% | 7.08% |
| Revenue Growth (5Y CAGR) | 12.1% | 11.8% |
| EPS Growth (3Y CAGR) | 19.6% | 3.06% |
| EPS Growth (5Y CAGR) | 26.3% | 7.64% |
Balance sheet
| Measure | Resmed | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.47B | $37.33M |
| Total Debt | $259.95M | $72.66M |
| Net Cash (Debt) | $1.21B | $3.92M |
| Net Cash Per Share | $8.38 | $0.28 |
| Equity (Book Value) | $6.59B | $57.36M |
| Book Value Per Share | $45.65 | $2.81 |
| Tangible Book Value | $3.22B | $10.71M |
| Working Capital | $2.93B | $54.64M |
Financial position
| Measure | Resmed | Industry median |
|---|---|---|
| Current Ratio | 3.10 | 2.50 |
| Quick Ratio | 1.80 | 1.54 |
| Debt / Equity | 0.04 | 0.38 |
| Debt / EBITDA | 0.12 | 2.31 |
| Debt / FCF | 0.16 | 3.50 |
| Net Debt / EBITDA | -0.58 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Resmed | Industry median |
|---|---|---|
| Operating Cash Flow | $1.81B | -$653.46K |
| Capital Expenditures | -$156.29M | -$3.69M |
| Free Cash Flow | $1.65B | -$835.02K |
| FCF Per Share | $11.44 | -$0.02 |
Efficiency
| Measure | Resmed | Industry median |
|---|---|---|
| Asset Turnover | 0.66 | 0.59 |
| Inventory Turnover | 2.35 | 2.21 |
| Revenue Per Employee | $497.23K | $322.75K |
| Profits Per Employee | $133.98K | -$52.11K |
| Employee Count | 11,370 | 197 |
Dividends and yields
| Measure | Resmed | Industry median |
|---|---|---|
| Earnings Yield | 4.40% | -6.92% |
| FCF Yield | 4.77% | -0.62% |
| Dividend Yield | 1.00% | 0.81% |
| Buyback Yield | 1.81% | 0.78% |
| Shareholder Yield | 2.81% | 0.84% |
| Dividend Per Share | $2.40 | $0.72 |
| Dividend Growth (YoY) | 13.2% | 4.80% |
| Years of Dividend Growth | 5 | 0 |
| Payout Ratio | 23.0% | 30.3% |
| FCF Payout Ratio | 21.2% | 21.9% |
Shares
| Measure | Resmed | Industry median |
|---|---|---|
| Shares Outstanding | 144,252,000 | 44,856,700 |
| Shares Change (YoY) | -0.87% | 3.35% |
| Shares Change (QoQ) | -0.55% | 0.27% |
| Float | 142,445,000 | 36,934,400 |
| Shares Held by Insiders | 1.25% | 10.6% |
| Shares Held by Institutions | 69.4% | 63.5% |
Taxes
| Measure | Resmed | Industry median |
|---|---|---|
| Income Tax | $396.12M | $1.52M |
| Effective Tax Rate | 20.6% | 18.6% |
Scores
| Measure | Resmed | Industry median |
|---|---|---|
| Graham Number | $103.50 | $34.37 |
| Graham Upside | -56.8% | -58.3% |
| Altman Z-Score | 11.57 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.67 | -2.64 |
Calculated by StockData from Resmed's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.